183 related articles for article (PubMed ID: 25711717)
21. Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily--a randomized, two-way crossover study.
Miehlke S; Madisch A; Kirsch C; Lindner F; Kuhlisch E; Laass M; Knoth H; Morgner A; Labenz J
Aliment Pharmacol Ther; 2005 Apr; 21(8):963-7. PubMed ID: 15813831
[TBL] [Abstract][Full Text] [Related]
22. Low-dose famotidine and effervescent cimetidine in healthy subjects: a placebo-controlled overnight pH study.
Reilly TG; Grimley CE; Usselmann B; Cottrell J; Mann SG; Raskin S; Nwokolo CU
Aliment Pharmacol Ther; 1998 May; 12(5):469-74. PubMed ID: 9663728
[TBL] [Abstract][Full Text] [Related]
23. Lansoprazole regimens that sustain intragastric pH > 6.0: an evaluation of intermittent oral and continuous intravenous infusion dosages.
Metz DC; Amer F; Hunt B; Vakily M; Kukulka MJ; Samra N
Aliment Pharmacol Ther; 2006 Apr; 23(7):985-95. PubMed ID: 16573801
[TBL] [Abstract][Full Text] [Related]
24. Oral buffered esomeprazole is superior to i.v. pantoprazole for rapid rise of intragastric pH: a wireless pH metry analysis.
Banerjee R; Reddy DN; Guda NM; Kalpala R; Mahurkar S; Darisetty S; Rao GV
J Gastroenterol Hepatol; 2010 Jan; 25(1):43-7. PubMed ID: 19874444
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of pentagastrin-induced gastric acid secretion by intravenous pantoprazole: a dose-response study.
Pisegna JR; Martin P; McKeand W; Ohning G; Walsh JH; Paul J
Am J Gastroenterol; 1999 Oct; 94(10):2874-80. PubMed ID: 10520836
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and Acid Suppressant Efficacy of Esomeprazole after Intravenous, Oral, and Subcutaneous Administration to Healthy Beagle Dogs.
Hwang JH; Jeong JW; Song GH; Koo TS; Seo KW
J Vet Intern Med; 2017 May; 31(3):743-750. PubMed ID: 28407418
[TBL] [Abstract][Full Text] [Related]
27. Safety, pharmacokinetics, and pharmacodynamics of S-(-)-pantoprazole sodium injections after single and multiple intravenous doses in healthy Chinese subjects.
Jiao HW; Sun LN; Li YQ; Yu L; Zhang HW; Wang MF; Yu LY; Yuan ZQ; Xie LJ; Chen J; Meng L; Zhang XH; Wang YQ
Eur J Clin Pharmacol; 2018 Mar; 74(3):257-265. PubMed ID: 29167917
[TBL] [Abstract][Full Text] [Related]
28. Four-day continuous gastric pH monitoring following anti-acid secretory drug administration: cross-over test to assess the early effects.
Suzuki T; Yamaguchi T; Odaka T; Kobayashi M; Seza A; Kouzu T; Yokosuka O
Aliment Pharmacol Ther; 2008 Jan; 27(1):66-71. PubMed ID: 17922801
[TBL] [Abstract][Full Text] [Related]
29. Esomeprazole 40 mg i.v. provides faster and more effective intragastric acid control than pantoprazole 40 mg i.v.: results of a randomized study.
Wilder-Smith CH; Röhss K; Bondarov P; Hallerbäck B; Svedberg LE; Ahlbom H
Aliment Pharmacol Ther; 2004 Nov; 20(10):1099-104. PubMed ID: 15569112
[TBL] [Abstract][Full Text] [Related]
30. Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects.
Armstrong D; Bair D; James C; Tanser L; Escobedo S; Nevin K
Aliment Pharmacol Ther; 2003 Oct; 18(7):705-11. PubMed ID: 14510744
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and pharmacodynamics of intravenous esomeprazole at 2 different dosages in dogs.
Seo DH; Lee JB; Hwang JH; Jeong JW; Song GH; Koo TS; Seo KW
J Vet Intern Med; 2019 Mar; 33(2):531-535. PubMed ID: 30548689
[TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of the effect of PO administered acid suppressants on gastric pH in healthy cats.
Ryan P; Odunayo A; Price J; Hecht S; Hillsman S; Galyon G; Steiner J; Tolbert MK
J Vet Intern Med; 2020 Sep; 34(5):1879-1885. PubMed ID: 32885499
[TBL] [Abstract][Full Text] [Related]
33. Low dose famotidine and cimetidine in single postprandial doses: a placebo controlled comparative study of overnight pH.
Reilly TG; Mann SG; Panos MZ; Walt RP
Gut; 1995 Sep; 37(3):325-8. PubMed ID: 7590425
[TBL] [Abstract][Full Text] [Related]
34. Low-dose famotidine and ranitidine as single post-prandial doses: a three-period placebo-controlled comparative trial.
Reilly TG; Singh S; Cottrell J; Mann SG; Stauffer L; Walt RP
Aliment Pharmacol Ther; 1996 Oct; 10(5):749-55. PubMed ID: 8899083
[TBL] [Abstract][Full Text] [Related]
35. Intragastric pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer.
van Rensburg CJ; Hartmann M; Thorpe A; Venter L; Theron I; Lühmann R; Wurst W
Am J Gastroenterol; 2003 Dec; 98(12):2635-41. PubMed ID: 14687809
[TBL] [Abstract][Full Text] [Related]
36. Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status.
Furuta T; Shirai N; Sugimoto M; Nakamura A; Okudaira K; Kajimura M; Hishida A
Aliment Pharmacol Ther; 2005 Jul; 22(1):67-74. PubMed ID: 15963082
[TBL] [Abstract][Full Text] [Related]
37. Effective administration method of intravenous proton pump inhibitor: a novel testing using a BRAVO catheterless pH monitoring system.
Kım KJ; Park MI; Park SJ; Cho SW; Moon W; Kim GM; Kim WM
Turk J Gastroenterol; 2011 Dec; 22(6):575-81. PubMed ID: 22287401
[TBL] [Abstract][Full Text] [Related]
38. Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions.
Ng FH; Wong SY; Lam KF; Chu WM; Chan P; Ling YH; Kng C; Yuen WC; Lau YK; Kwan A; Wong BC
Gastroenterology; 2010 Jan; 138(1):82-8. PubMed ID: 19837071
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of a long-acting injectable formulation of omeprazole in healthy dogs.
Odunayo A; Galyon G; Price J; Hecht S; Tolbert MK
J Vet Intern Med; 2022 Jul; 36(4):1416-1421. PubMed ID: 35546514
[TBL] [Abstract][Full Text] [Related]
40. Effect of esomeprazole and rabeprazole on intragastric pH in healthy Chinese: an open, randomized crossover trial.
Li ZS; Zhan XB; Xu GM; Cheng NN; Liao Z
J Gastroenterol Hepatol; 2007 Jun; 22(6):815-20. PubMed ID: 17565634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
